Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia

被引：14

作者：

Abad, S

Moachon, L

Blanche, P

Bavoux, F

Sicard, D

Salmon-Céron, D

机构：

[1] Univ Paris 05, Hop Cochin St Vincent de Paul, Serv Med Interne 2, F-75679 Paris 14, France

[2] Univ Paris 05, Hop Cochin St Vincent de Paul, Serv Pharmacol Pharmacovigilance, F-75679 Paris, France

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2001年 / 52卷 / 04期

关键词：

cytochrome P450; drug interactions; hypoglycaemia; metabolism; sulphonylureas;

D O I：

10.1046/j.0306-5251.2001.01456.x-i2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：456 / 457

页数：2

共 6 条

[1]

GIRARDIN E, 1992, ANN MED INTERNE, V143, P11

[2]

Komatsu K, 2000, DRUG METAB DISPOS, V28, P475

[3] A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia [J].

OBrien, JG ;

Dong, BJ ;

Coleman, RL ;

Gee, L ;

Balano, KB .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :854-859

[4]

POND SM, 1977, CLIN PHARMACOL THER, V22, P573

[5] Gliclazide hydroxylation by rat liver microsomes [J].

Rieutord, A ;

Stupans, I ;

Shenfield, GM ;

Gross, AS .

XENOBIOTICA, 1995, 25 (12) :1345-1354

[6] Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance [J].

Venkatakrishnan, K ;

von Moltke, LL ;

Greenblatt, DJ .

CLINICAL PHARMACOKINETICS, 2000, 38 (02) :111-180

← 1 →